Everest Medicines is a Hong Kong-listed (HKEX 1952.HK) biopharmaceutical company focused on developing, manufacturing and commercializing transformative pharmaceutical products and vaccines that address critical unmet medical needs for patients in Greater China and other Asian Pacific markets.
